Background Multimodal recovery programmes decrease hospital stay. The objective of this systematic review was to assess how single-modality evidence-based care principles, regarding postoperative analgesia and postoperative nausea and vomiting (PONV) prophylaxis, combine to achieve this. Methods A systematic review of randomised controlled trials was performed. Relevant trials compared postoperative epidural analgesia/parenteral opioid analgesia/ paracetamol/non-steroidal anti-infl ammatory drugs (NSAIDs) and postoperative antiemetics. The effect on recovery was evaluated in terms of length of hospital stay, pain intensity, duration of gastrointestinal dysfunction and incidence of PONV. Results Twenty-three trials were included. Epidural anaesthesia failed to reduce length of stay or the incidence of PONV when compared to controls. Pain intensity and time to fi rst bowel movement were reduced (p<0.05). Paracetamol did not reduce the incidence of PONV. NSAIDs reduced postoperative opioid consumption and the incidence of PONV (p<0.05). Dexamethasone and 5-HT3 antagonists reduced the incidence of PONV compared to controls.
Introduction
Recent studies have demonstrated that the combination of single-modality evidence-based care principles into a multimodal effort enhances postoperative recovery leading to improvements in patient outcome. 1 The enhanced recovery after surgery (ERAS) group recommendations 2 integrated a range of perioperative interventions in order to improve postoperative recovery and enhance hospital discharge. These recommendations included a tailored anaesthetic using thoracic epidural catheters followed by non-opioid analgesics after the epidural is removed. Effective management of postoperative pain improves clinical outcome. 3 Persistent postoperative gastrointestinal dysfunction prolongs inpatient length of stay (LOS). 4 Recognition of the complications associated with poor postoperative pain control 5 has resulted in a greater awareness and subsequent improvement in management.
Systemic opioid administration, previously the mainstay of postoperative analgesia, delays the restoration of gastrointestinal function and can impede discharge. 6 The administration of opioids and non-steroidal antiinfl ammatory drugs (NSAIDs) in conjunction is designed to reduce side-effect profi les of opioid analgesics (OA) following the removal of the epidural. 7 8 Combination analgesia is effective and allows a reduction in dosage, further minimising opioid-related side effects.
Postoperative nausea and vomiting (PONV) has been identifi ed as an essential component in achieving patient satisfaction 9 and can be more distressing than pain. 10 11 Untreated, one third of patients who undergo surgery will experience PONV, which is associated with prolonged stays in recovery, wound dehiscences and pulmonary complications. 12 PONV assessment allows appropriate antiemetic administration. A previous history of PONV, female gender, non-smoking and postoperative opioid administration are the most important predictors of developing PONV. 13 This review will assess the evidence for individual treatments for postoperative pain, nausea and vomiting and whether they reduce hospital LOS, pain scores and gastrointestinal dysfunction. Questions to be addressed include whether the use of midthoracic epidural analgesia compared to intravenous opioids is effective in reducing length of hospital stay, postoperative pain scores and preventing gastrointestinal dysfunction and whether treatments reduce postoperative pain, nausea and vomiting. This review is primarily focused on outcomes in colorectal surgery, however studies from a range of surgical disciplines have been included in order to maximise the available evidence for review.
Methods
The National Library of Medicine's PubMed database, the Cochrane Register and Embase were all searched for relevant studies between January 1995 and August 2011. The medical subject heading (MeSH) terms used to review the literature were 'colon', 'sigmoid', 'rectal', 'abdominal surgery', 'orthopaedic surgery', 'urological surgery', 'obstetrics', 'gynaecology', 'ear', 'nose', 'throat', 'epidural, ' 'analgesia, ' 'nausea' and 'vomiting. ' Additional studies were identifi ed from hand searches of the bibliographies of selected publications as per PRISMA guidelines.
Inclusion criteria
Studies that were deemed of suitable design for inclusion were randomised (RCT) or clinical controlled trial in adults undergoing elective surgery. Studies that were included compared epidural analgesia with local anaesthetic versus parenteral opioid/non-OA. Studies assessing opioid consumption following paracetamol, NSAIDs or placebo administration and those that compared strategies to prevent PONV were also included.
Outcomes
Postoperative epidural analgesia and parenteral opioid administration were assessed in terms of 'LOS' as a primary outcome measure. Secondary outcome measures included visual analogue pain scores (VAS), time taken to recover bowel function and incidence of PONV.
The effectiveness of paracetamol and NSAIDs were assessed by the additional requirement of opioid administration in the fi rst 24 h after surgery. Secondary opioid-related outcomes included incidence of nausea and vomiting. The incidence of PONV in the fi rst 24 h was also assessed following general anaesthetic (GA).
Results

Identification of trials
Twenty relevant articles were identifi ed that compared epidural anaesthesia and OA. Five literature reviews were excluded, three were 'letters to the Editor', two were prospective studies lacking controls and two retrospective studies were all excluded. Eight randomised controlled trials subsequently remained and were analysed.
Nineteen studies were identifi ed that assessed paracetamol/NSAID and opioid consumption. Six literature reviews were excluded. Three prospective studies lacked controls and one retrospective study were also excluded. Seventeen relevant publications evaluating PONV were identifi ed. Six narrative reviews, three letters, two retrospective studies and two prospective studies lacking controls were also excluded. The remaining trials were of satisfactory design to merit inclusion for analysis.
Postoperative data was compared using the χ 2 test for categorical variables and Wilcoxon rank sum test for continuous variables in all included studies with the exception of the study by Sun et al, 14 which use Fisher's exact test for categorical data and Tukey's multicomparison test for continuous data.
Analysis of LOS, VAS and recovery of bowel function in epidural analgesia versus parenteral OA after surgery
Of the RCTs analysed, comparing epidural analgesia (EA) with local anaesthetic and parenteral OA, seven of the studies used thoracic bupivacaine and fentanyl [15] [16] [17] [18] [19] [20] [21] and one study used thoracic ropivacaine and fentanyl. 22 Established perioperative recovery programmes were frequently used and were based on multimodal analgesia (NSAIDs and paracetamol), PONV prophylaxis and early mobilisation. There was no statistically signifi cant difference in LOS data between the epidural analgesia and control group (CG) (table 1) in any trial. Pain was assessed by the VAS at 24 h in seven studies, 15 17-22 48 h in six studies 15 17 18 20-22 and at 72 h in six studies. 15 17-19 21 22 Epidurals reduced VAS to a greater degree than systemic opioid administration (p<0.05) in all of the studies. Six studies 15-17 20-22 examined the time to fi rst bowel movement. Four demonstrated a signifi cant reduction in the epidural group 15 17 20 22 (p<0.05). The incidence of PONV was recorded in fi ve studies. 15 17 19 21 22 None of the studies established a signifi cant difference between groups (p<0.05).
Analysis of opioid reduction with paracetamol and NSAID administration
Nine trials were included (tables 2 and 3). Three studies used paracetamol or propacetamol, fi ve used NSAIDs (three types) and one study compared propacetamol and an NSAID. 23 One study assessed the effi cacy of two types of NSAIDs. 24 All trials were placebo controlled. In all trials, patients received patient controlled analgesia (PCA) morphine for at least 24 h after surgery. A range of surgical procedures were included: orthopaedic (4 studies), gynaecological (1 study), obstetric (1 study), urological (one study) and general surgery (two studies).
Hernandez-Palazon et al 25 demonstrated a signifi cant reduction (p<0.05) in morphine consumption in the paracetamol group compared to placebo. There was no reduction in the incidence of PONV in any paracetamol study. All of the RCT's that assessed NSAIDs revealed a significant reduction (p<0.05) in opioid consumption after major surgery (table 3) . 23 24 26-29 A statistically signifi cant reduction in the incidence of PONV was observed in three 24 26 29 out of the four trials in which it was measured.
Analysis of treatments preventing PONV
Six trials were included, all of which were placebo controlled (tables 4 and 5). A prospective factorial trial of six interventions 12 preventing PONV included all of the interventions recommended by the ERAS protocol. These included total intravenous anaesthesia (TIVA) and the administration of intravenous dexamethasone and ondansetron. Two RCT's assessed the effi cacy of TIVA in reducing the incidence of PONV. 12 30 Both studies demonstrated a statistically signifi cant reduction in the incidence of PONV in the TIVA group compared to the traditional anaesthesia group. No signifi cant reduction in PONV was observed at 48 or 72 h postoperatively. 30 Three RCTs 12 31 32 assessed the effi cacy and timing of the administration of intravenous dexamethasone. All trials demonstrated a signifi cant reduction in PONV with dexamethasone compared to placebo. In one trial, 31 dexamethasone administered at the start of surgery caused a signifi cant reduction in the incidence of PONV in the immediate postoperative period (<2 h) compared to administration at the end of surgery. However, there were no statistically signifi cant differences between the two groups at 24 h.
Four RCTs 12 14 33 34 assessed the effi cacy and timing of 5-HT3 antagonist administration in preventing PONV. Three trials 12 33 34 demonstrated a signifi cant improvement in PONV in the treatment group compared to placebo. In one trial, 12 the 5-HT3 antagonist was given at the end of surgery, while in the other two trials, 33 34 it was given at induction. Where a direct comparison of the timing of administration of 5-HT3 antagonists was made, no signifi cant differences were found.
Discussion
This systematic review questions the role of epidural analgesia within the context of the ERAS protocol. Epidural analgesia does not shorten the duration of hospital stay or reduce the incidence of PONV after surgery. There is a signifi cant reduction in the duration of ileus and VAS pain scores, however. Taguchi et al 35 demonstrated that the development of a postoperative ileus is a signifi cant side effect following gastrointestinal surgery and delays recovery. Gastrointestinal dysfunction is also dependent upon anaesthetic and opioid administration. 36 Epidural catheter insertion may, however, be associated with inadequate pain management and technical failure. The appropriateness of their role in fast-track colonic surgery is open to debate. 20 Rigg et al 37 in their large RCT of epidural analgesia removed 40% of all epidural catheters inserted, either due to inadequate analgesia or malposition.
Multimodal analgesia, whereby morphine is administered with other non-OA, is used to reduce the cumulative morphine dose administered, and therefore morphinerelated side effects, such as PONV. 38 This review demonstrates that postoperative NSAIDs are more effective than paracetamol when combined with PCA morphine and reduce opioid consumption and PONV, concurring with previous publications. 39 PCA morphine consumption is an indirect but useful approximation of the effi cacy of other analgesics that have also been administered. Patients in CGs consumed, on average, 48 mg of morphine in the fi rst 24 h. This amount was reduced by 35-40% with concurrent NSAID administration and by 15% by concurrent paracetamol consumption. The numbers of patients recruited in the trials assessed were comparatively small but the heterogeneity of the data sets precludes meta-analysis.
Combination use of paracetamol and NSAID is superior to paracetamol alone. 27 Paracetamol failed to reduce the incidence of PONV in any trial reviewed. The analgesic effect of paracetamol is proportional to the amount and rate of administration. It has been recommended that loading doses optimise effects. 40 This systematic review demonstrates that NSAID administration reduces morphine requirements and results in a signifi cant reduction in PONV. 23 But indiscriminate usage of NSAIDs, without due consideration to a patient's comorbidities, is ill advised due to the potential complications of bleeding and cardiac or renal dysfunction. The use of non-selective NSAIDs, such as diclofenac, has been shown to increase the risk of adverse cardiovascular events. 41 Non-selective NSAID use is also associated with adverse effects including a reduction in renal perfusion, thought to be secondary to reduced synthesis of vasodilatory prostaglandins such as PGE-2. 42 It has also been demonstrated that statistically signifi cant increases occur in postoperative bleeding time. 43 The evidence accrued from this review reveals that the use of epidural analgesia in colorectal surgery confers no benefi t in reducing PONV. Apfel et al 12 PONV occurs in 59% of all patients undergoing GA with inhalational agents and nitrous oxide. The use of propofol reduces the risk of PONV by 19% and avoiding nitrous oxide by 12%. Combining propofol and air reduces the risk of PONV by 25%. 44 Current ERAS recommendations advise the use of 5-hydroxytryptamine (5-HT3) receptor antagonists (ondansetron) and steroids (dexamethasone). These antiemetics are currently recommended for patients at moderate to severe risk of PONV. Ondansetron and dexamethasone are equally effective and each independently reduce the risk of PONV by 25%. 12 No statistically signifi cant difference in the incidence of PONV was seen between the administration of 5-HT3 receptor antagonist at GA induction and the end of surgery. 14 In conclusion, following surgery, epidural analgesia does not shorten the duration of hospital stay or reduce the incidence of PONV after surgery, though it may reduce the duration of ileus and pain scores. NSAIDs and paracetamol confer quantifi able morphine-sparing effects. NSAIDs provide a statistically signifi cant reduction in morphine consumption and PONV. Combinations of non-OA act synergistically, have fewer complications and are more effective than a single non-opioid alone and for this reason, should be administered in the perioperative period.
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